A fully automated, high-throughput newborn screening platform that performs every stage of an assay — from sample plate retrieval to measurement and result reporting. Designed specifically for dried blood spot (DBS) testing, the GSP supports DELFIA immunoassay and enzymatic technologies and integrates GSP Workstation software to deliver outstanding accuracy, reliability, and operational efficiency for modern neonatal screening programs.
Features
• Fully automated end-to-end assay processing.
• Continuous sample loading from integrated plate stacker.
• GSP Workstation software for newborn screening data management.
• Comprehensive barcode identification of all materials.
• Multi-technology support for DELFIA immunoassay and enzymatic testing.
• Integrated platform designed specifically for newborn screening laboratories.
Benefits
• Minimizes hands-on time and reduces risk of human error.
• Enables flexible workflows and uninterrupted high-throughput operation.
• Ensures high sensitivity and reliable assay performance.
• Simplifies user training and supports rapid staff adoption.
• Maximizes operational efficiency with newborn screening-specific informatics.
• Supports scalable growth and future expansion of screening programs.
Disorders Supported
| Disorder |
| Biotinidase (BTD) Deficiency |
| Congenital Adrenal Hyperplasia (CAH) |
| Congenital Hypothyroidism |
| Cystic Fibrosis |
| Galactosemia |
| Glucose-6-phosphate Dehydro-genase (G6PD) Deficiency |
| Phenylketonuria (PKU) |
